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The molecular dynamics simulation of the binding domain of a glutamate receptor presented in this
issue of Structure (Lau & Roux, 2007) provides insights into large-scale fluctuations of this protein
that are supported by experiment and provide constraints on possible models for the function of
the intact glutamate receptor.Glutamate receptors are the major
excitatory neurotransmitter receptors
in the mammalian central nervous
system and are involved in a range of
neurologicaldiseases (Parkinson’s and
Alzheimer’s diseases, Huntington’s
chorea, and epilepsy) and in normal
physiological processes, such as
learning and memory. Drugs targeted
to these receptors have enormous
potential for treating neurological and
psychiatric disorders. One of the im-
portant breakthroughs in the study of
these receptors was the isolation of
a soluble binding domain and the solu-
tion of the crystal structure (Armstrong
et al., 1998). Although the binding do-
main represents an isolated portion of
the intact protein, it binds agonists
and antagonists with an affinity similar
to the intact protein and has become
an important model system for under-
standing the relationship between the
structure and dynamics of the binding
domain and the overall function of the
protein. The crystal structures have
provided a wealth of information on
the structure of the binding site and
have suggested clues to the coupling
betweenbinding, channelopening, and
desensitization. However, the crystal
structures are largely static and may,
in some cases, be affected by crystal
packing. Obviously, it is the motion of
the protein that provides the initial
signal that is transmitted to the ion
channel and considerable effort has
been made to understand the solu-
tion behavior of the binding domain us-
ing NMR spectroscopy (Ahmed et al.,
2007), FTIR spectroscopy (Cheng et al.,
2002), fluorescence spectroscopy
(Abele et al., 2000), and small-angle
X-ray scattering (Madden et al., 2005),
as well as computational methods(Arinaminpathy et al., 2002; Mamonova
et al., 2005). Each of these methods
has provided new information highlight-
ing different aspects of the structure
and dynamics of this important protein.
The protein consists of two lobes that
are often assumed to move as rigid
bodies, with the ligand-binding site be-
tween the two lobes. Upon binding of
agonist, the lobes close and envelope
the ligand, and a modest correlation
has been observed between the de-
gree of lobe closure in some crystal
structures and the efficacy of an ago-
nist. However, even the crystal struc-
tures suggest that the relative lobe
orientation is not static. NMR (A.S.
Maltsev and R.E.O., unpublished data),
fluorescence (Ramanoudjame et al.,
2006), and small-angle X-ray measure-
ments (Madden et al., 2005) report on
the average solution structure, which
is in some cases, different from the
crystal structure.
Lau and Roux (2007) used all-atom
molecular dynamics in conjunction
with umbrella sampling to compute
the free energy landscape of the bind-
ing domain in the apo state, bound to
an anagonist (DNQX) and bound to
the natural ligand (glutamate). Two
distances (x1 and x2; Figure 1) were
defined between the lobes (defined
by the center of mass of groups of
2–3 sequential residues in each lobe)
that capture the degree of lobe closure
and possible twists of one lobe relative
to the other, and the starting coordi-
nates for the umbrella sampling were
positioned along x1 and x2. The overall
results are completely consistent with
previous experiments and simulations,
but do add important details. That is,
the free energy landscapes (described
by the [x1,x2] order parameter) suggestStructure 15, October 2007 ª2a protein for which the relative orienta-
tion of the two lobes in the apo state is
extremely flexible, somewhat less flex-
ible in the antagonist-bound state, and
relatively, but not completely, rigid in
the full agonist-bound state. In fact,
the results suggest that, in the apo
state, the relative orientation of the
two lobes can be considerably more
open than that observed in the apo
crystal structure (Figure 1). This hyper-
extension of the structure has been
observed in the crystal structure of an
antagonist-bound form (Kasper et al.,
2006) but has not yet been observed
directly in an apo crystal structure.
However, as described in the paper,
ensemble average scatter profiles
calculated from the simulation trajec-
tories match the small-angle X-ray
scattering data (Madden et al., 2005)
better than profiles computed from
the crystal structures, suggesting that
in solution these hyperextended forms
may exist. These results are also con-
sistent with 19F NMR data (Ahmed
et al., 2007), which show clearly that
the apo form is very flexible. This is in-
ferred from the dynamics of the four
19F-labeled tryptophans, one of which
is in the cleft between the two lobes.
In the case of a similar antagonist
(CNQX), the tryptophan in the cleft
shows at least two different states,
and for the glutamate-bound form,
this tryptophan is relatively rigid.
Another interesting result of these
studies is a suggestion as to the steps
in the binding process, which poten-
tially represent the reaction coordi-
nate. Again, at least on a superficial
level, the results are consistent with
experiment. The idea that binding first
occurs to lobe 1 (docking) followed by
closure of lobes and interaction with007 Elsevier Ltd All rights reserved 1157
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PreviewsFigure 1. Structures of the S1S2 GluR2 Protein with the Two Lobes Opened by 16
(Blue) and 30 (Green) Relative to the Glutamate-Bound Structure, 1FTJ
This represents the range of openings represented by 91% of the conformational ensemble. The
two distances shown (x1 and x2) were used to determine the two-dimensional order parameter.lobe 2 (locking) has been proposed
previously (Abele et al., 2000), but
these simulations present a plausible
pathway leading from the open state
through two intermediates to a closed
and fully bound state. Furthermore, the
energetics of the process (stabilization
of 9–12 kcal/mol) is similar to that
obtained with isothermal titration calo-
rimetry (approximately 8 kcal/mol,
Madden et al., 2000).
The main interest in the motions of
this protein is the idea that the closure
of the lobes around the agonist forms
the first step in the process leading to1158 Structure 15, October 2007 ª2007the opening of the ion channel. The re-
ceptor is formed from four subunits,
each of which contains a copy of the
S1S2 binding domain. Results from
single channel recording at varying ag-
onist concentrations have led to the
notion that the conductance level of
the channel may be correlated with
the number of binding sites occupied,
but it is not clear if simple closure of
the lobes directly opens a conducting
path in the ion channel or if lobe clo-
sure increases the probability that the
channel will open, with other parts of
the protein contributing essential rolesElsevier Ltd All rights reserved(Oswald, 2004). Partial agonists, which
in some cases bind with high affinity,
preferentially populate lower conduc-
tance states. Extension of these stud-
ies to the free energy landscapes for
partial agonists will be of considerable
value for restraining possible models
of channel activation.
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